Transcenta Holding Limited 創勝集團醫藥有限公司

Please note that due to the planned shutdown of Webb-site.com, the directors, officers and advisers of HK-listed companies will cease to be updated effective 2025-03-31. Appointments and resignations effective on or before that date will be recorded, as will advisers recorded in annual reports filed on or before that date. We intend to make a data dump available after processing the final filings.
Snapshot date:
exclude unknown removal dates

Main board

Name ⚥ Age
in
2026		 Position From Until
1 Bao, Jun (Impact Therapeutics) 包駿 M 59 INEDIndependent Non-Executive Director 2021-09-14 2023-08-23
2 Chen, Helen Wei 陳瑋 F 59 INEDIndependent Non-Executive Director 2023-08-23
3 Qian, Xueming 錢雪明 M 58 CEOChief Executive Officer 2012-10-18 2024-06-07
Ch, CEOChairman, Chief Executive Officer 2024-06-07
4 Shi, Michael Ming 石明 M 60 EDExecutive Director 2021-03-31 2022-07-20
5 Srinivasan, Kumar M 62 INEDIndependent Non-Executive Director 2022-12-19
6 Tang, Jiasong 唐稼松 M 52 INEDIndependent Non-Executive Director 2021-09-14
7 Weng, Xiaolu 翁曉路 M 50 FDFinance Director 2022-03-21 2024-04-30
8 Xu, Li (1956) 徐莉 F 70 NEDNon-Executive Director 2024-08-28
9 Zhang, Zhihua (1982) 張志華 M 44 INEDIndependent Non-Executive Director 2021-09-14
10 Zhao, Jonathan Yining 趙奕寧 M 54 NED, ChNon-Executive Director, Chairman 2018-12-01 2024-06-07
11 Zhu, Albert Da 朱達 M 45 EDExecutive Director 2021-03-31 2022-06-26

Manager/adviser/other

Name ⚥ Age
in
2026		 Position From Until
1 Leung, Kwan Wai (1981) 梁君慧 F 45 CoSecCompany Secretary
2 Weng, Xiaolu 翁曉路 M 50 CFOChief Financial Officer 2021-12-17 2022-03-21
CFOChief Financial Officer 2024-04-30
3 Zhu, Albert Da 朱達 M 45 CoSecCompany Secretary 2022-06-26

Copyright & disclaimer, Privacy policy

Back to top